article thumbnail

Insulin statistics 2025

The Checkup by Singlecare

Insulin can be divided into three types ( JAMA , 2024): Human Analog Biosimilar From 2016 to 2020, insulin analogs and insulin biosimilars were the most commonly used insulin types in the U.S., Diabetes Care , 2020) Between 2014 and 2019, the monthly out-of-pocket cost for insulin users with insurance coverage rose from $49 to $58.

article thumbnail

Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis

IDStewardship

An accessible guide encompassing key subjects in epidemiology, diagnosis, laboratory considerations, treatment, medication, co-morbidities, special circumstances, monitoring, and managing adverse reactions. Geneva, World Health Organization, 2020. 2011;365(23):2155–2166. World Health Organization.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. 1991;68(3):499-501. doi:10.1002/1097-0142(19910801)68:3 3.0.co;2-f European Medicines Agency. Accessed July 21, 2025. link] NHS England.

article thumbnail

9 Sneaky Thyroid Toxins Hiding in Your Home

The Thyroid Pharmacist

An adverse reaction to mold can be a trigger for Hashimotos, asthma, and other autoimmune conditions. [23] May 5, 2020. Accessed March 30, 2020. Accessed November 14, 2020. Updated March 5, 2020. Accessed November 14, 2020. Published 2020 Jun 4. Integr Med (Encinitas). 2024;23(1):22-26. [3]

article thumbnail

STAT+: Experts critique flawed system for monitoring drugs’ side effects in wake of asthma drug report

STAT

and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address. Experts say that the Singulair incident highlights a flawed system, both in the U.S.

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This can be achieved by reducing the burden of adverse reactions or by optimising benefits through patient selection (eg, contraindications, recommendations of use, warnings, concomitant medicine[s], or certain test parameters) and treatment management (eg, specific dosing regimen, relevant testing, patient follow-up).

article thumbnail

New Bill could enhance UK clinical trial regulation

European Pharmaceutical Review

He highlighted research by the Association of the British Pharmaceutical Industry (ABPI) from 2022, which found that between 2018 and 2020, “the median time between application for regulatory approval and delivery of a first dose to a participant in a trial increased by almost a month.”